Credit Suisse Upgrades Humana (HUM) to Outperform; Trump Black Swan Event

Credit Suisse upgraded Humana (NYSE: HUM) from Neutral to Outperform with a price target of $210.00 (from $175.00) for the Trump Black Swan event.

Analyst Scott Fidel commented, "The election of Donald Trump as the next President and the Republican sweep of Congress could have an impact on equity values that may likely go well beyond the initial stock price moves since the elections. In our election playbook preview, we highlighted that a Trump win represents a clear positive for Diversified MCO stocks and a clear negative for the stocks of Hospitals and Medicaid MCOs. In this report, we refresh our ratings and price targets across our coverage universe to align exactly with this thesis. The bottom line is that we are now more positive on the outlook for the Diversified MCO stocks; we see particularly bright prospects ahead for Medicare Advantage (MA) under a Trump administration. Conversely, we see new clouds of uncertainty swirling around the stocks of companies that are highly leveraged to the Affordable Care Act (ACA) as a driver of their growth stories, namely Hospitals and Medicaid MCOs."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $192.88 yesterday.

You May Also Be Interested In

• Assa Abloy (ASSAB:SS) (ASAZY) PT Raised to SEK275 at Citi
• Community Health (CYH) PT Lowered to $4.50 at Oppenheimer
• Atlas Copco AB (ATCOA:SS) (ATLKY) PT Raised to SEK150 at RBC Capital